MediaAlpha (MAX) Q4 2025 earnings review
P&C Strength Masks Health Drag and Tax-Distorted Earnings
MediaAlpha's headline 365% Net Income surge to $34.0M is a mirage, entirely fueled by a $138M tax benefit and skewed by a massive $124M charge related to its Tax Receivables Agreement. Under the hood, operating profitability is decelerating: Adjusted EBITDA fell 16% YoY to $30.8M, weighed down by the deliberate wind-down of the under-65 Health segment and a mix-shift toward the lower-margin Private Marketplace. However, the core Property & Casualty (P&C) business remains a powerhouse, with Transaction Value jumping 38%. Management is projecting absolute confidence, doubling its buyback authorization to $100M and guiding for a return to double-digit revenue growth in 26Q1.
🐂 Bull Case
The Board doubled its share repurchase authorization to $100M. The remaining $86M covers roughly 15% of outstanding shares, providing a massive floor for the stock over the next year.
P&C transaction value hit a record $552M in Q4. Carriers are highly profitable and spending heavily on market-share acquisition, driving sustained growth.
🐻 Bear Case
A massive mix-shift toward Private Marketplace transactions (now 53.7% of total vs 41.0% last year) is compressing revenue conversion. Revenue fell 3% YoY despite Transaction Value growing 23%.
The strategic reset of the under-65 health business is crushing consolidated margins. Health Transaction Value dropped 40% in Q4 and is guided to halve (-50%) in 26Q1.
⚖️ Verdict: ⚪
Neutral leaning Bullish. The GAAP financials are a noisy mess of tax benefits and liability charges, and the Health segment is bleeding. But the underlying P&C engine is remarkably healthy, and a 15% share buyback program signals deep management conviction.
Key Themes
The P&C Engine Continues to Hum
Property & Casualty is carrying the entire company. While YoY percentage growth is decelerating due to increasingly tough comps (down from 639% in 24Q4 to 38% in 25Q4), absolute dollar volume continues to break records, hitting $552M in Q4. Management expects the momentum to continue, guiding for ~35% YoY growth in 26Q1 as carriers enjoy peak underwriting margins and invest heavily in customer acquisition.
Health Segment Drag is Accelerating
The strategic scale-back of the under-65 Health vertical following FTC scrutiny continues to severely punish consolidated metrics. Health Transaction Value declined 40% YoY in Q4 to $54.3M, and management's 26Q1 guidance calls for an even steeper 50% plunge. This segment's higher historical margins mean its absence is disproportionately hurting Adjusted EBITDA.
Private Marketplace Shift Crushes Revenue Conversion
MediaAlpha reported a bizarre divergence in Q4: Transaction Value grew 23%, but Revenue declined 3%. The culprit is a mix-shift. Private Marketplace transactions (where MediaAlpha only books a fee, not gross spend) spiked to 53.7% of total Transaction Value, up from 41.0% a year ago. If this shift from the Open Marketplace is structural rather than cyclical, top-line revenue growth will remain artificially suppressed.
Massive GAAP Distortions
Do not look at GAAP Net Income this quarter. The company reported a $34.0M Net Income, a 365% YoY surge. However, this was entirely manufactured by a $138.1M income tax benefit. Operating Loss before taxes was actually $104.2M, driven primarily by a $124.2M non-operating charge to increase the Tax Receivables Agreement (TRA) liability. Adjusted EBITDA provides the only clean view of the quarter.
Share Buyback Signals Deep Value Conviction
In a massive vote of confidence, the Board increased the share repurchase authorization by $50M to a total of $100M. With $14.4M already deployed, the remaining $85.6M represents roughly 15% of the company's outstanding shares. Management explicitly stated they expect to complete the 'vast majority' of this program by the end of 2026, providing substantial downside protection.
Other KPIs
Decelerating. Down 16% YoY from $36.7M in 24Q4. However, the optics here are heavily skewed by the intentional destruction of the under-65 Health segment. Excluding the U-65 Health business, management notes that Adjusted EBITDA actually grew approximately 10% YoY.
Accelerating. Up 43% YoY from $45.9M in 2024. Despite the extreme noise in GAAP net income due to TRA liabilities and FTC legal reserves, the actual cash-generation engine of the business is highly robust, easily funding the aggressive share repurchase program.
Guidance
Stable. The $582.5M midpoint represents a 23% YoY increase, identical to the 23% growth achieved in 25Q4. P&C is expected to carry the load with ~35% growth, completely offsetting a brutal ~50% expected decline in Health.
Reversing. After shrinking 3% in Q4, revenue is guided to grow 12% YoY at the midpoint. This implies management expects the aggressive shift toward Private Marketplace transactions to normalize slightly, allowing revenue to better track Transaction Value growth.
Reversing. Expected to grow 4% YoY at the midpoint, breaking the negative trajectory seen in Q4. Stripping out the dying under-65 health segment, management expects core Adjusted EBITDA to jump a very healthy 25% YoY.
Key Questions
Private Marketplace Structural Shift
Private Marketplace transactions spiked to nearly 54% of total Transaction Value. Is this a permanent structural shift driven by the consolidation of carrier spend at the top, or do you expect Open Marketplace participation to rebound as Tier 2 and Tier 3 carriers ramp up ad budgets?
Health Segment Baseline
With Health Transaction Value guided down another 50% in Q1, at what specific point in 2026 do we lap the under-65 scale-backs and establish a true baseline for the segment to grow again?
TRA Liability Cash Impact
You recorded a massive $124M charge to increase the Tax Receivables Agreement liability. Over what timeframe will this $124M turn into actual cash outflows, and how does it impact your ability to fully execute the $100M buyback?